Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Kingworld Medicines Group Ltd. ( (HK:1110) ) has provided an update.
Kingworld Medicines Group Ltd. has announced the adoption of the 2025 Share Award Scheme, replacing the 2019 Share Award Scheme, which is set to expire in August 2025. This move is in line with the latest changes to Chapter 17 of the Listing Rules and does not require shareholder approval as it involves existing shares. Additionally, the company has terminated the 2021 Share Option Scheme due to non-compliance with the updated Listing Rules and has no plans to grant further share options under this scheme. The termination of these schemes and the introduction of the new one aim to align with regulatory requirements and optimize the company’s share award strategy.
More about Kingworld Medicines Group Ltd.
YTD Price Performance: 12.09%
Average Trading Volume: 1,212,303
Technical Sentiment Signal: Buy
Current Market Cap: HK$309.3M
Learn more about 1110 stock on TipRanks’ Stock Analysis page.